Association of derived neutrophil-to-lymphocyte ratio (dNLR) with pathological complete response (pCR) after neoadjuvant chemotherapy (CT)

被引：0

作者：

Ocana, A. ^{[1
]}

Chacon, Jil-M. ^{[2
]}

Calvo, L. ^{[3
]}

Anton, A. ^{[4
]}

Mansutti, M. ^{[5
]}

Alba, E. ^{[6
]}

Lluch, A. ^{[7
]}

Lahuerta, A. ^{[8
]}

Bisagni, G. ^{[9
]}

Bermejo, B. ^{[7
]}

Semiglazov, V. ^{[10
]}

Thill, M. ^{[11
]}

Chan, A. ^{[12
]}

Morales, S. ^{[13
]}

Albanell, J. ^{[14
]}

Herranz, J. ^{[15
]}

Trias Bes, I. Tusquets ^{[14
]}

Valagussa, P. ^{[16
]}

Chiesa, M. ^{[17
]}

Gianni, L. ^{[16
]}

机构：

[1] Hosp Gen Univ Albacete, Med Oncol, Albacete, Spain

[2] Hosp Hosp Virgen de la Salud, Med Oncol, Toledo, Spain

[3] Complejo Hosp Univ A Coruna, Med Oncol, La Coruna, Spain

[4] Hosp Univ Miguel Servet, Med Oncol, Zaragoza, Spain

[5] Azienda Sanit Univ Integrata Udine, Osped Santa Maria della Misericordia, Oncol, Udine, Italy

[6] Hosp Clin Univ Virgen de la Victoria, Med Oncol, Malaga, Spain

[7] Univ Valencia, Biomed Res Inst INCLIVA, Hosp Clin Valencia, Dept Med Oncol, Valencia, Spain

[8] Fdn Onkol, Med Oncol, San Sebastian, Spain

[9] Azienda Osped Arcispedale Santa Maria Nuova, IRCCS, Med Oncol, Reggio Emilia, Italy

[10] NN Petrov Natl Med Res Ctr Oncol, Med Oncol, St Petersburg, Russia

[11] Agaplesion, Kliniken Markus Krankenhaus, Med Oncol, Frankfurt, Germany

[12] Breast Canc Res Ctr BCRC WA, Med Oncol, Nedlands, WA, Australia

[13] Hosp Univ Arnau de Vilanova Lleida, Med Oncol, Lleida, Spain

[14] Univ Hosp Mar, Med Oncol, Barcelona, Spain

[15] GEICAM Spanish Breast Canc Grp, Stat, Madrid, Spain

[16] Fdn Michelangelo, Med Oncol, Milan, Italy

[17] GEICAM Spanish Breast Canc Grp, Translat Res, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

271P

引用

页码：91 / +

页数：2

共 50 条

[1] Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Ocana, Alberto
Chacon, Jose Ignacio
Calvo, Lourdes
Anton, Antonio
Mansutti, Mauro
Albanell, Joan
Martinez, Maria Teresa
Lahuerta, Ainhara
Bisagni, Giancarlo
Bermejo, Begona
Semiglazov, Vladimir
Thill, Marc
Chan, Arlene
Morales, Serafin
Herranz, Jesus
Tusquets, Ignacio
Chiesa, Massimo
Caballero, Rosalia
Valagussa, Pinuccia
Bianchini, Giampaolo
Alba, Emilio
Gianni, Luca
[J]. FRONTIERS IN ONCOLOGY, 2022, 11
[2] Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Graziano, Vincenzo
Grassadonia, Antonino
Iezzi, Laura
Vici, Patrizia
Pizzuti, Laura
Barba, Maddalena
Quinzii, Alberto
Camplese, Annarita
Di Marino, Pietro
Peri, Marta
Veschi, Serena
Alberti, Saverio
Gamucci, Teresa
Di Gioacchino, Mario
De Tursi, Michele
Natoli, Clara
Tinari, Nicola
[J]. BREAST, 2019, 44 : 33 - 38
[3] Association of neutrophil-to-lymphocyte ratio with pathological complete response in locally advanced breast cancer
Munoz-Arcos, Laura S.
Weiner, Ashley
Moon, Jee-Young
Xue, Xionan
Anampa-Mesias, Jesus
[J]. CANCER RESEARCH, 2021, 81 (04)
[4] Association between pretreatment neutrophil to lymphocyte ratio (NLR) and complete pathological response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NACT).
Clarke, Kaethe Vivienne
Amir, Eitan
Berman, Hal K.
Maganti, Manjula
Sridhar, Srikala S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
Gao, Siming
Tang, Wenjie
Zuo, Bingli
Mulvihill, Lianne
Yu, Jinming
Yu, Yishan
[J]. FRONTIERS IN ONCOLOGY, 2023, 12
[6] The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Jiaqiang Dan
Jinya Tan
Junhua Huang
Xiaoli Zhang
Yao Guo
Yunkun Huang
Jin Yang
[J]. Breast Cancer, 2020, 27 : 982 - 988
[7] The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Dan, Jiaqiang
Tan, Jinya
Huang, Junhua
Zhang, Xiaoli
Guo, Yao
Huang, Yunkun
Yang, Jin
[J]. BREAST CANCER, 2020, 27 (05) : 982 - 988
[8] The predictive value of neutrophil-to-lymphocyte ratio on overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy.
Tang, Wenjie
Wang, Linlin
Yu, Jinming
Yu, Yishan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[9] Prognostic implications of the peripheral platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer patients
Jin, Xiaoyan
Wang, Ke
Shao, Xuan
Huang, Jian
[J]. GLAND SURGERY, 2022, 11 (06) : 1057 - 1066
[10] Pretreatment platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a predictor of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: single center experience from Turkey
Acikgoz, Ozgur
Yildiz, Anil
Bilici, Ahmet
Olmez, Omer Fatih
Basim, Pelin
Cakir, Asli
[J]. ANTI-CANCER DRUGS, 2022, 33 (10) : 1150 - 1155

← 1 2 3 4 5 →